Stockreport

iTeos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

iTeos Therapeutics, Inc.  (ITOS) 
PDF WATERTOWN, Mass. and GOSSELIES, Belgium, Jan. 08, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneeri [Read more]